Expression Table for this CRE
| SRX690762 | Mdr2-KO liver male etiology/histology:70% AD, 10% HCC | 68.6 |
| SRX7078886 | PanIN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; p53f/+ PDA | 66.9 |
| CNhs13757 | Tracheal epithelial cells, differentiation to ciliated epithelial cells, 024hr, biol_rep3 | 66.5 |
| SRX690765 | Mdr2-KO liver male etiology/histology:50% AD, 20% HCC | 65.9 |
| SRX690763 | Mdr2-KO liver female etiology/histology:10% AD, 20% HCC | 63.3 |
| SRX690764 | Mdr2-KO liver male etiology/histology:60% AD, 10% HCC | 60.3 |
| SRX690759 | Mdr2-KO liver male etiology/histology:20% AD, 0% HCC | 56.7 |
| SRX690754 | Mdr2-KO liver male etiology/histology:Inflammation | 50.8 |
| SRX690756 | Mdr2-KO liver male etiology/histology:Inflammation | 50.8 |
| SRX690750 | WT liver male etiology/histology:WT | 50.3 |
| CNhs13259 | ST2 (Mesenchymal stem cells) cells, differentiation to osteocytes, 00hr15min, biol_rep2 (015mB2) | 50.0 |
| SRX4504817 | mouse NET-CAGE kidney samples, biol_rep2 | 50.0 |
| SRX690753 | WT liver male etiology/histology:WT | 49.9 |
| SRX690761 | Mdr2-KO liver male etiology/histology:70% AD, 20% HCC | 48.5 |
| SRX690751 | WT liver male etiology/histology:WT | 47.9 |
| SRX690757 | Mdr2-KO liver female etiology/histology:40% AD, 0% HCC | 46.5 |
| SRX690758 | Mdr2-KO liver male etiology/histology:30% AD, 0% HCC | 45.9 |
| SRX690760 | Mdr2-KO liver male etiology/histology:60% AD, 0% HCC | 44.6 |
| SRX690752 | WT liver male etiology/histology:WT | 44.0 |
| SRX690748 | WT liver male etiology/histology:WT | 43.8 |
| SRX4504814 | mouse NET-CAGE kidney samples, biol_rep1 | 43.7 |
| SRX690749 | WT liver male etiology/histology:WT | 43.6 |
| CNhs10507 | ovary, adult | 42.4 |
| SRX690755 | Mdr2-KO liver male etiology/histology:Inflammation | 42.1 |
| CNhs10493 | pituitary gland, adult | 39.4 |
| SRX7078888 | IPMN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; Brg1f/f PDA | 39.2 |
| SRX690770 | Mdr2-KO liver male etiology/histology:70% AD, 10% HCC | 38.8 |
| CNhs10492 | skin, adult | 38.8 |
| SRX690773 | Mdr2-KO liver male etiology/histology:70% AD, 20% HCC | 37.4 |
| CNhs10513 | whole body, embryo E17.5 | 34.0 |
| CNhs14335 | natural helper cells, IL2 treated, day15, biol_rep3 | 34.0 |
| SRX690766 | Mdr2-KO liver female etiology/histology:30% AD, 40% HCC | 33.7 |
| CNhs10476 | mammary gland, adult pregnant day19 | 33.2 |
| SRX690771 | Mdr2-KO liver female etiology/histology:80% AD, 10% HCC | 33.2 |
| SRX7078887 | PanIN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; p53f/+ PDA | 31.6 |
| SRX690772 | Mdr2-KO liver female etiology/histology:80% AD, 10% HCC | 31.3 |
| SRX690768 | Mdr2-KO liver male etiology/histology:80% AD, 20% HCC | 31.2 |
| SRX690769 | Mdr2-KO liver male etiology/histology:70% AD, 30% HCC | 31.2 |
| SRX690767 | Mdr2-KO liver male etiology/histology:80% AD, 10% HCC | 31.1 |
| CNhs10598 | forelimb, embryo E17 | 30.8 |
| CNhs14112 | ES-46C embryonic stem cells, neuronal differentiation, day03, biol_rep2 | 30.3 |
| CNhs13296 | ST2 (Mesenchymal stem cells) cells, differentiation to adipocytes, 02hr, biol_rep3 (002hA3) | 30.1 |
| CNhs11519 | macrophage, TB infection, stimulated BMDM+IL-13(aaMph), with Mtb, 048hr(024h after stimulation), biol_rep1 | 29.7 |
| CNhs13260 | ST2 (Mesenchymal stem cells) cells, differentiation to osteocytes, 00hr30min, biol_rep2 (030mB2) | 29.4 |
| CNhs11215 | skin, neonate N03 | 29.2 |
| CNhs11205 | eyeball, neonate N02 | 29.1 |
| CNhs11520 | macrophage, TB infection, stimulated BMDM+IL-13(aaMph), with Mtb, 072hr(048h after stimulation), biol_rep1 | 28.0 |
| CNhs10582 | intestine, embryo E17 | 27.9 |
| CNhs14093 | ES-OS25 embryonic stem cells, untreated control, biol_rep3 | 26.1 |
| SRX4504808 | mouse CAGE kidney samples, biol_rep2 | 25.7 |